Date : 22 April 2026

| Companies | Headquarter | Offerings |
| Strayer Corporation | Michigan, U.S. | Flow diverters, detachable coils, stents, and neurovascular embolization devices |
| Medtronic | Dublin, Ireland | Flow diversion systems, embolization coils, and endovascular treatment devices |
| MicroPort Scientific Corporation | Shanghai, China | Coil embolization systems and neurovascular intervention devices |
| Johnson & Johnson | New Jersey, U.S. | Neurovascular stents, embolization systems, and aneurysm treatment solutions |
| Terumo Corporation | Tokyo, Japan | Microcatheters, guidewires, and aneurysm flow disruption devices |
| Penumbra, Inc | California, U.S. | Catheter-based neurovascular access and embolization solution |
Clinical Trials
R&D
Patient Support and Services
The global intracranial aneurysm market size was estimated at USD 2.45 billion in 2025 and is predicted to increase from USD 2.66 billion in 2026 to approximately USD 5.64 billion by 2035, expanding at a CAGR of 8.7% from 2026 to 2035.

Speak with a healthcare analyst about your research, consulting, or platform needs.